Timing of Red Blood Cell Transfusions and Occurrence of Necrotizing Enterocolitis : A Secondary Analysis of a Randomized Clinical Trial

Medientyp: E-Artikel

Titel: Timing of Red Blood Cell Transfusions and Occurrence of Necrotizing Enterocolitis : A Secondary Analysis of a Randomized Clinical Trial : A Secondary Analysis of a Randomized Clinical Trial

Beteiligte: Salas, Ariel A.; Gunn, Elizabeth; Carlo, Waldemar A.; Bell, Edward F.; Das, Abhik; Josephson, Cassandra D.; Patel, Ravi M.; Tan, Sylvia; Kirpalani, Haresh; Polin, Richard A.; Laptook, Abbot R.; Keszler, Martin; Hensman, Angelita M.; Little, Emily; St. Pierre, Lucille; Vieira, Elisa; Walsh, Michele C.; Hibbs, Anna Maria; Newman, Nancy S.; Payne, Allison H.; Wilson-Costello, Deanne E.; Siner, Bonnie S.; Bhola, Monika; Yalcinkaya, Gulgun; [...]

Erschienen: American Medical Association (AMA), 2024

Sprache: Englisch

DOI: 10.1001/jamanetworkopen.2024.9643

ISSN: 2574-3805

Entstehung:

Anmerkungen:

Beschreibung: ImportanceObservational studies often report that anemia and red blood cell (RBC) transfusions are associated with a higher risk of necrotizing enterocolitis (NEC) among extremely low-birthweight (ELBW) infants.ObjectiveTo evaluate whether there is a temporal association between 72-hour hazard periods of exposure to RBC transfusions and NEC among ELBW infants randomized to either higher or lower hemoglobin transfusion thresholds.Design, Setting, and ParticipantsThis post hoc secondary analysis of 1690 ELBW infants who survived to postnatal day 10 enrolled in the Transfusion of Prematures (TOP) randomized multicenter trial between December 1, 2012, and April 12, 2017, was performed between June 2021 and July 2023.ExposuresFirst, the distribution of RBC transfusions and the occurrence of NEC up to postnatal day 60 were examined. Second, 72-hour posttransfusion periods were categorized as hazard periods and the pretransfusion periods of variable duration as control periods. Then, the risk of NEC in posttransfusion hazard periods was compared with that in pretransfusion control periods, stratifying the risk based on randomization group (higher or lower hemoglobin transfusion threshold group).Main Outcomes and MeasuresThe primary outcome was incidence of NEC stage 2 or 3. Secondary outcomes included the incidence rates of NEC within five 10-day intervals, taking into account the number of days at risk.ResultsOf 1824 ELBW infants randomized during the TOP trial, 1690 were included in the present analysis (mean [SD] gestational age, 26.0 [1.5] weeks; 899 infants [53.2%] were female). After categorizing 4947 hazard periods and 5813 control periods, we identified 133 NEC cases. Fifty-nine of these cases (44.4%) occurred during hazard periods. Baseline and clinical characteristics of infants with NEC during hazard periods did not differ from those of infants with NEC during control periods. The risk of NEC was 11.9 per 1000 posttransfusion hazard periods and 12.7 per 1000 control periods (adjusted risk ratio, 0.95; 95% CI, 0.68-1.32; P = .74). This risk did not differ significantly between randomization groups, but the incidence rate of NEC per 1000 days peaked between postnatal days 20 and 29 in the lower hemoglobin transfusion threshold group.Conclusions and RelevanceThe findings of this post hoc analysis suggest that, among ELBW infants with the hemoglobin ranges occurring in the TOP trial, exposure to RBC transfusions was not temporally associated with a higher risk of NEC during 72-hour posttransfusion hazard periods. Given that the incidence rate of NEC peaked between postnatal days 20 and 29 among infants with lower hemoglobin values, a more in-depth examination of this at-risk period using larger data sets is warranted.Trial RegistrationClinicalTrials.gov Identifier: NCT01702805

Zugangsstatus: Freier Zugang

Nur in Feld suchen:

Zuletzt gesuchte Begriffe: